Crossmark

The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin

Published Online: 2020-08-27

Published Print: 2021-01

Authors

Maayah, Zaid H.

Takahara, Shingo

Dyck, Jason R. B. https://orcid.org/0000-0002-7045-2884
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research (167280)
License Information

Text and Data Mining valid from 2020-08-27

Version of Record valid from 2020-08-27
More Information

Article History

Received: 12 May 2020

Accepted: 12 August 2020

First Online: 27 August 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current